4
Changes in Ownership
Tango Therapeutics, Inc. Filed Acc 0000950170-24-012996
Chief Financial Officer sold 3,725 shares at an average $12.59 ($46,900)
From the SEC's structured data for this filing
Trades in this filing
Beckman Daniella · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-06 | Sale : show line 1 in the form | −1,908 | $12.56 | $23,969 | 134,214 | D |
| 2024-02-07 | Sale : show line 2 in the form | −1,817 | $12.62 | $22,930 | 132,397 | D |
| Open-market sales · 3,725 sh · avg $12.59 · $46,900 | ||||||
Loading xslF345X05/ownership.xml…